Skip to content
healthcare.dev

Bendeka

NDC 63459-348, bendamustine hydrochloride, injection, solution, from Teva Pharmaceuticals USA, Inc..

Product NDC
63459-348
Status
Listed
Labeler
Teva Pharmaceuticals USA, Inc.
Dosage form
INJECTION, SOLUTION
Route
INTRAVENOUS
Product type
HUMAN PRESCRIPTION DRUG
Marketing category
NDA
Application
NDA208194
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/63459-348 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • BENDAMUSTINE HYDROCHLORIDE25 mg/mL

Pharmacologic classes

Alkylating Activity [MoA]; Alkylating Drug [EPC]

Package NDCNDC-11Package
63459-348-04634590348041 VIAL, MULTI-DOSE in 1 CARTON (63459-348-04) / 4 mL in 1 VIAL, MULTI-DOSE

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

  • FDA label sections

    GET /v1/drugs/labels/ace9a43b-f9bd-4896-abfe-0ef4fec67ddf
  • Medicare Part B payment limits (ASP)

    GET /v1/drugs/asp?ndc=63459-348

Use it

Look up 63459-348 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/63459-348 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 63459-348. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.